Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
J. Kotthaus, T. Steinmetzer, J. Kotthaus, D. Schade, A. van de Locht & B. Clement. (2010) Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase. Xenobiotica 40:2, pages 93-101.
Read now
Read now
Susan Hurst, Cho-Ming Loi, Joanne Brodfuehrer & Ayman El-Kattan. (2007) Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology 3:4, pages 469-489.
Read now
Read now
K. Umehara, Y. Shimokawa, T. Koga, T. Ohtani & G. Miyamoto. (2004) Oxidative one-carbon cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes. Xenobiotica 34:1, pages 61-71.
Read now
Read now
S. Marini, E. Grasso, V. Longo, P. Puccini, B. Riccardi & P. Giovanni Gervasi. (2003) 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human. Xenobiotica 33:1, pages 1-11.
Read now
Read now
M. Chiba, J. A. Nishime, W. Neway, Y. Lin & J. H. Lin. (2000) Comparative in vitro metabolism of indinavir in primates - a unique stereoselective hydroxylation in monkey. Xenobiotica 30:2, pages 117-129.
Read now
Read now
R. D. WHALEN, P. N. V. TATA§G. J. BURCKART†R. VENKATARAMAN*. (1999) Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica 29:1, pages 3-9.
Read now
Read now
D. K. WALKER. (1999) Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29:3, pages 297-310.
Read now
Read now
K. Taguchi, T. Konishi, H. Nishikawa & S. Kitamura. (1999) Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid. Xenobiotica 29:9, pages 899-907.
Read now
Read now
K. C. BEAUMONT, N. J. CUSSANS, D. J. NICHOLS & D. A. SMITH. (1998) Pharmacokinetics and metabolism of darifenacin in the mouse, rat, dog and man. Xenobiotica 28:1, pages 63-75.
Read now
Read now
S. MARINI. (1998) Xenobiotic-metabolizing enzymes in pig nasal and hepatic tissues. Xenobiotica 28:10, pages 923-935.
Read now
Read now
R. T. Coutts, Mimi V. Bach & G. B. Baker. (1997) Metabolism of amitriptyline with CYP2D6 expressed in a human cell line. Xenobiotica 27:1, pages 33-47.
Read now
Read now
D. A. SMITH. (1997) Pharmacokinetics and pharmacodynamics in toxicology. Xenobiotica 27:5, pages 513-525.
Read now
Read now
A. NAKAMURA*T. HIROTA, A. MORINO, T. SHIMADA & T. UEMATSU. (1997) N-oxidation of irsogladine by the CYP2C subfamily in the rat, dog, monkey and man. Xenobiotica 27:10, pages 995-1003.
Read now
Read now
K. UMEHARA, S. KUDO & M. ODOMI. (1997) Involvement of CYP2D1 in the metabolism of carteolol by male rat liver microsomes. Xenobiotica 27:11, pages 1121-1129.
Read now
Read now
M. J. Humphrey. (1996) Application of Metabolism and Pharmacokinetic Studies to the Drug Discovery Process. Drug Metabolism Reviews 28:3, pages 473-489.
Read now
Read now
D. F. V. Lewis, P. J. Eddershaw, P. S. Goldfarb & M. H. Tarbit. (1996) Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica 26:10, pages 1067-1086.
Read now
Read now
S. G. Jezequel, S. Uden & P. Wastall. (1996) Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man. Xenobiotica 26:9, pages 963-975.
Read now
Read now
W. M. Zweers-zeilmaker, J. Batzias, R. F. M. Maas, G. J. Horbach, A. S. J. P. A. M. van Miert & R. F. Witkamp. (1996) In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): Substrate activities and effects of inducers. Xenobiotica 26:11, pages 1131-1141.
Read now
Read now
K. C. Beaumont, A. G. Causey, P. E. Coates & D. A. Smith. (1996) Pharmacokinetics and metabolism of zamifenacin in mouse, rat, dog and man. Xenobiotica 26:4, pages 459-471.
Read now
Read now
M. Spatzenegger & W. Jaeger. (1995) Clinical Importance of Hepatic Cytochrome P450 in Drug Metabolism. Drug Metabolism Reviews 27:3, pages 397-417.
Read now
Read now
M. Berg-Candolfi, B. Dulery, F. Jehl & K. D. Haegele. (1995) Metabolism and pharmacokinetics of the cardiotonic agent piroximone and of its major metabolite in dog. Xenobiotica 25:1, pages 59-70.
Read now
Read now
Steven A. Wrighton, Mark Vandenbranden, Jeffrey C. Stevens, Lisa A. Shipley, Barbara J. Ring, John R. Cashman & Allan E. Rettie. (1993) In Vitro Methods for Assessing Human Hepatic Drug Metabolism: Their use in Drug Development. Drug Metabolism Reviews 25:4, pages 453-484.
Read now
Read now
Steven A. Wrighton & Jeffrey C. Stevens. (1992) The Human Hepatic Cytochromes P450 Involved in Drug Metabolism. Critical Reviews in Toxicology 22:1, pages 1-21.
Read now
Read now
M. J. Humphrey & D. A. Smith. (1992) Role of metabolism and pharmacokinetic studies in the discovery of new drugs—present and future perspectives. Xenobiotica 22:7, pages 743-755.
Read now
Read now
D. A. Smith, H. S. Rasmussen, D. A. Stopher & D. K. Walker. (1992) Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man. Xenobiotica 22:6, pages 709-719.
Read now
Read now
Articles from other publishers (115)
R. Lock, P. J. H. Webborn, C. W. Vose & R. M. J. Ings. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
265
297
.
Shayne Cox Gad & Dexter SullivanJr.Jr.. 2023. Drug Safety Evaluation. Drug Safety Evaluation
425
456
.
Milos Mihajlovic & Mathieu Vinken. (2022) Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods. International Journal of Molecular Sciences 23:6, pages 3315.
Crossref
Crossref
Yvonne Chang, Lisbeth K. Siddens, Lauren K. Heine, David A. Sampson, Zhen Yu, Kay A. Fischer, Christiane V. Löhr & Susan C. Tilton. (2019) Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface. Toxicology and Applied Pharmacology 379, pages 114644.
Crossref
Crossref
Theodore P. RasmussenKristen Buck & Nicole I. zur Nieden. 2018. Stem Cells in Birth Defects Research and Developmental Toxicology. Stem Cells in Birth Defects Research and Developmental Toxicology
91
117
.
Benoit B. N’guessan, Seth K. Amponsah, George J. Dugbartey, Kwabena D. Awuah, Eunice Dotse, Abigail Aning, Kennedy K. E. Kukuia, Isaac J. Asiedu-Gyekye & Regina Appiah-Opong. (2018) In Vitro Antioxidant Potential and Effect of a Glutathione-Enhancer Dietary Supplement on Selected Rat Liver Cytochrome P450 Enzyme Activity. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-8.
Crossref
Crossref
Giuseppe Mazza, Walid Al-Akkad & Krista Rombouts. (2017) Engineering in vitro models of hepatofibrogenesis. Advanced Drug Delivery Reviews 121, pages 147-157.
Crossref
Crossref
Ayman F. El-Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
35
76
.
Jiaqi Mi, Manman Zhao, Shu Yang, Yufei Jia, Yan Wang, Baolian Wang, Jing Jin, Xiaojian Wang, Qiong Xiao, Jinping Hu & Yan Li. (2017) Identification of cytochrome P450 isoforms involved in the metabolism of Syl930, a selective S1PR 1 agonist acting as a potential therapeutic agent for autoimmune encephalitis. Drug Metabolism and Pharmacokinetics 32:1, pages 53-60.
Crossref
Crossref
Shayne Cox Gad. 2016. Drug Safety Evaluation. Drug Safety Evaluation
381
411
.
Adeel Sattar, Shuyu Xie, Lingli Huang, Zahid Iqbal, Wei Qu, Muhammad A. Shabbir, Yuanhu Pan, Hafiz I. Hussain, Dongmei Chen, Yanfei Tao, Zhenli Liu, Mujahid Iqbal & Zonghui Yuan. (2016) Pharmacokinetics and Metabolism of Cyadox and Its Main Metabolites in Beagle Dogs Following Oral, Intramuscular, and Intravenous Administration. Frontiers in Pharmacology 7.
Crossref
Crossref
Guanyong Su, Alana K. Greaves, Daniel Teclechiel & Robert J. Letcher. (2016) In Vitro Metabolism of Photolytic Breakdown Products of Tetradecabromo-1,4-diphenoxybenzene Flame Retardant in Herring Gull and Rat Liver Microsomal Assays. Environmental Science & Technology 50:15, pages 8335-8343.
Crossref
Crossref
Christophe Furger. 2016. Live Cell Assays. Live Cell Assays
229
246
.
Michaël Maes, Mathieu Vinken & Hartmut Jaeschke. (2016) Experimental models of hepatotoxicity related to acute liver failure. Toxicology and Applied Pharmacology 290, pages 86-97.
Crossref
Crossref
Yoshiaki OHTSUDhiren R. THAKKER, Jacqueline A. GIBBONSKenjiro TSUBOTAShohei OTSUKAHiroshi ARAI. (2015) Determination of the Androgen Receptor Inhibitor Enzalutamide and its Metabolites in Animal Plasma and Brain Homogenates Using LC-MS/MS and its Application to Pharmacokinetic Studies. CHROMATOGRAPHY 36:3, pages 115-122.
Crossref
Crossref
Richard B. Silverman & Mark W. Holladay. 2014. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
357
422
.
Shayne Cox GadEugenia Kraynov & Martin E. Dowty. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Douglas K. Spracklin, Amit S. Kalgutkar & Angus N. R. Nedderman. 2014. Reducing Drug Attrition. Reducing Drug Attrition
97
137
.
M. A. EDMONDSON, S. H. DURAN, D. M. BOOTHE, A. J. STEWART & W. R. RAVIS. (2012) Pharmacokinetics of tramadol and its major metabolites in alpacas following intravenous and oral administration. Journal of Veterinary Pharmacology and Therapeutics 35:4, pages 389-396.
Crossref
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
209
227
.
Anna Astashkina, Brenda Mann & David W. Grainger. (2012) A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacology & Therapeutics 134:1, pages 82-106.
Crossref
Crossref
Alexander V. LyubimovJoshua G. DeKeyser & Magang Shou. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
38
.
Helen J. Renaud, Julia Yue Cui, Mohammed Khan & Curtis D. Klaassen. (2011) Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in Mice. Toxicological Sciences 124:2, pages 261-277.
Crossref
Crossref
Wolfgang Dekant & Spiridon Vamvakas. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Ayman El‐Kattan, Susan Hurst, Joanne Brodfuehrer & Cho‐Ming Loi. 2011. Oral Bioavailability. Oral Bioavailability
253
265
.
S. COX, T. MARTIN-JIMENEZ, S. Van AMSTEL & T. DOHERTY. (2011) Pharmacokinetics of intravenous and intramuscular tramadol in llamas. Journal of Veterinary Pharmacology and Therapeutics 34:3, pages 259-264.
Crossref
Crossref
S Wanwimolruk, S Nyika, M Kepple, D G Ferry & C R Clark. (1993) Effects of Capsaicin on the Pharmacokinetics of Antipyrine, Theophylline and Quinine in Rats. Journal of Pharmacy and Pharmacology 45:7, pages 618-621.
Crossref
Crossref
Krista Dobo, Don Walker & Andrew Teasdale. 2011. Genotoxic Impurities. Genotoxic Impurities
151
167
.
Claude Charuel. 2011. Pharmaceutical Toxicology in Practice. Pharmaceutical Toxicology in Practice
83
107
.
Angus N. R. Nedderman & Don K. Walker. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
131
143
.
Sebastien Carnicella, Dao‐Yao He, Quinn V. Yowell, Stanley D Glick & Dorit Ron. (2010) Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration. Addiction Biology 15:4, pages 424-433.
Crossref
Crossref
Makiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama & Yuichi Sugiyama. (2010) In Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical Parameters. Drug Metabolism and Disposition 38:8, pages 1362-1370.
Crossref
Crossref
Salim A. Bastaki, Nawal Osman, Jose Kochiyil, Mohamed Shafiullah, Rengasamy PadmanabhanYousef M. Abdulrazzaq. (2010) Toxicokinetics of Aflatoxin in Pregnant Mice. International Journal of Toxicology 29:4, pages 425-431.
Crossref
Crossref
. 2010. Drug Safety Evaluation. Drug Safety Evaluation
568
618
.
Shayne Cox Gad. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shayne Cox GadSonu Sundd Singh. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Christopher L. Shaffer, Mithat Gunduz, Tim F. Ryder & Thomas N. O'Connell. (2010)
Species Differences in the Biotransformation of an α
4
β
2
Nicotinic Acetylcholine Receptor Partial Agonist: The Effects of Distinct Glucuronide Metabolites on Overall Compound Disposition
. Drug Metabolism and Disposition 38:2, pages 292-301.
Crossref
Crossref
Angelika Langsch, Shibashish Giri, Ali Acikgöz, Inka Jasmund, Bernd Frericks & Augustinus Bader. (2009) Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture. Toxicology Letters 188:3, pages 173-179.
Crossref
Crossref
Norie Murayama, Naoki Kaneko, Kana Horiuchi, Katsuhiro Ohyama, Makiko Shimizu, Katzuhiko Ito & Hiroshi Yamazaki. (2009) Cytochrome P450-depedent Drug Oxidation Activity of Liver Microsomes from Microminipigs, A Possible New Animal Model for Humans in Non-clinical Studies. Drug Metabolism and Pharmacokinetics 24:4, pages 404-408.
Crossref
Crossref
Robert P. Hunter & Ramiro Isaza. (2008) Concepts and Issues with Interspecies Scaling in Zoological Pharmacology. Journal of Zoo and Wildlife Medicine 39:4, pages 517-526.
Crossref
Crossref
Annalisa Nannelli, Vera Chirulli, Vincenzo Longo & P. Giovanni Gervasi. (2008) Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252:1-3, pages 105-112.
Crossref
Crossref
Alison Betts, Fidelma Atkinson, Iain Gardner, David Fox, Rob Webster, Kevin Beaumont & Paul Morgan. (2007)
Impact of Physicochemical and Structural Properties on the Pharmacokinetics of a Series of α1
L
-Adrenoceptor Antagonists
. Drug Metabolism and Disposition 35:8, pages 1435-1445.
Crossref
Crossref
Sompon Wanwimolruk & Preeya Wanwimolruk. (2006) Characterization of CYP1A enzyme in Adélie penguin liver. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 144:2, pages 148-154.
Crossref
Crossref
Mette Gillberg, Mette T. Skaanild & Christian Friis. (2006) Regulation of Gender-Dependent CYP2A Expression in Pigs: Involvement of Androgens and CAR. Basic & Clinical Pharmacology & Toxicology 98:5, pages 480-487.
Crossref
Crossref
Melissa A. McKinney, Sylvain De Guise, Daniel Martineau, Pierre Béland, Augustine Arukwe & Robert J. Letcher. (2006) Biotransformation of polybrominated diphenyl ethers and polychlorinated biphenyls in beluga whale (Delphinapterus leucas) and rat mammalian model using an in vitro hepatic microsomal assay. Aquatic Toxicology 77:1, pages 87-97.
Crossref
Crossref
Hiroyuki Kawahigashi, Sakiko Hirose, Kenjirou Ozawa, Yoshiko Ido, Misaki Kojima, Hideo Ohkawa & Yasunobu Ohkawa. (2005) Analysis of Substrate Specificity of Pig CYP2B22 and CYP2C49 towards Herbicides by Transgenic Rice Plants. Transgenic Research 14:6, pages 907-917.
Crossref
Crossref
Arun Kulkarni. 2005. Developmental and Reproductive Toxicology. Developmental and Reproductive Toxicology
525
570
.
. 2005. Drug Metabolism. Drug Metabolism
243
268
.
Khawja A. Usmani, Ernest Hodgson & Randy L. Rose. (2004) In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol. Chemico-Biological Interactions 150:3, pages 221-232.
Crossref
Crossref
Wolfgang Dekant & Spiridon Vamvakas. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Melissa A McKinney, Augustine Arukwe, Sylvain De Guise, Daniel Martineau, Pierre Béland, André Dallaire, Stéphane Lair, Michel Lebeuf & Robert J Letcher. (2004) Characterization and profiling of hepatic cytochromes P450 and phase II xenobiotic-metabolizing enzymes in beluga whales (Delphinapterus leucas) from the St. Lawrence River Estuary and the Canadian Arctic. Aquatic Toxicology 69:1, pages 35-49.
Crossref
Crossref
Eugene Olajos. 2004. Riot Control Agents. Riot Control Agents
37
64
.
Richard B. Silverman. 2004. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
405
495
.
Eva Anzenbacherová, Pavel Anzenbacher, Zbyněk Svoboda, Jitka Ulrichová, Jaroslav Květina, Jana Zoulová, František Perlík & Jiřina Martínková. (2003) Minipig as a model for drug metabolism in man: Comparison of in vitro and in vivo metabolism of propafenone. Biomedical Papers 147:2, pages 155-159.
Crossref
Crossref
Shahriar Haji-Momenian, Jayson M Rieger, Timothy L Macdonald & Milton L Brown. (2003) Comparative molecular field analysis and QSAR on substrates binding to cytochrome P450 2D6. Bioorganic & Medicinal Chemistry 11:24, pages 5545-5554.
Crossref
Crossref
S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker & N. Wood. (2003) THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN. Drug Metabolism and Disposition 31:6, pages 731-741.
Crossref
Crossref
Han van de Waterbeemd & Barry C Jones. 2003.
1
59
.
Jill S. Warrington, Lisa L. von Moltke, Richard I. Shader & David J. Greenblatt. (2002) In Vitro Biotransformation of Sildenafil (Viagra) in the Male Rat: The Role of CYP2C11. Drug Metabolism and Disposition 30:6, pages 655-657.
Crossref
Crossref
R. Zuber, Eva Anzenbacherová & P. Anzenbacher. (2007) Cytochromes P450 and experimental models of drug metabolism. Journal of Cellular and Molecular Medicine 6:2, pages 189-198.
Crossref
Crossref
Alexis B. Ulrich, Jens Standop, Bruno M. Schmied, Matthias B. Schneider, Terence A. Lawson & Parviz M. Pour. (2016) Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas. Toxicologic Pathology 30:2, pages 247-253.
Crossref
Crossref
D.F.V Lewis & M Dickins. (2002) Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. Toxicology 170:1-2, pages 45-53.
Crossref
Crossref
J. H. Lin. 2002. Pharmacokinetic Challenges in Drug Discovery. Pharmacokinetic Challenges in Drug Discovery
33
47
.
. 2002. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists
121
168
.
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
Genevieve Ubeaud, Claus-Ditter Schiller, Fabrice Hurbin, Daniel Jaeck & Philippe Coassolo. (2001) Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers. European Journal of Drug Metabolism and Pharmacokinetics 26:1-2, pages 37-45.
Crossref
Crossref
David F.V. Lewis. (2000) On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochemical Pharmacology 60:3, pages 293-306.
Crossref
Crossref
G. J. Muirhead, J. Harness, P. R. Holt, S. Oliver & R. J. Anziano. (2001) Ziprasidone and the pharmacokinetics of a combined oral contraceptive. British Journal of Clinical Pharmacology 49:S1, pages 49-56.
Crossref
Crossref
Sompon Wanwimolruk, Hu Zhang, Peter F Coville, Dorothy J Saville & Lloyd S Davis. (1999) In vitro hepatic metabolism of a CYP3A-mediated drug, quinine, in Adélie penguins. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 124:3, pages 301-307.
Crossref
Crossref
Annarita Meneguz, Stefano Fortuna, Paola Lorenzini & Maria Teresa Volpe. (1999) Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo. Experimental and Toxicologic Pathology 51:4-5, pages 392-396.
Crossref
Crossref
D.F.V. Lewis, M. Dickins, P.J. Eddershaw, M.H. Tarbit & P.S. Goldfarb. (1999) Cytochrome P450 Substrate Specificities, Substrate Structural Templates and Enzyme Active Site Geometries. Drug Metabolism and Drug Interactions 15:1, pages 1-50.
Crossref
Crossref
M. Monshouwer, G.A.E. van't Klooster, S.M. Nijmeijer, R.F. Witkamp & A.S.J.P.A.M. van Miert. (1998) Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicology in Vitro 12:6, pages 715-723.
Crossref
Crossref
J Molpeceres, M Chacón, L Berges, J.L Pedraz, M Guzmán & M.R Aberturas. (1998) Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose. International Journal of Pharmaceutics 174:1-2, pages 9-18.
Crossref
Crossref
K.M.L. Crommentuyn, J.H.M. Schellens, J.D. van den Berg & J.H. Beijnen. (1998) In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide. Cancer Treatment Reviews 24:5, pages 345-366.
Crossref
Crossref
Mariëlla E. M. Kuilman, Roel F. M. Maas, David J. Judah & Johanna Fink-Gremmels. (1998)
Bovine Hepatic Metabolism of Aflatoxin B
1
. Journal of Agricultural and Food Chemistry 46:7, pages 2707-2713.
Crossref
Crossref
Pierre Wolkenstein, Chanthavy Tan, Sylvaine Lecoeur, Janine Wechsler, Nadine Garcia-Martin, Dominique Charue, Martine Bagot & Philippe Beaune. (1998) Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chemico-Biological Interactions 113:1, pages 39-50.
Crossref
Crossref
William B. Mattes & Albert P. Li. (1997) Quantitative reverse transcriptase/PCR assay for the measurement of induction in cultured hepatocytes. Chemico-Biological Interactions 107:1-2, pages 47-61.
Crossref
Crossref
A Kern, A Bader, R Pichlmayr & K.-F Sewing. (1997) Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochemical Pharmacology 54:7, pages 761-772.
Crossref
Crossref
G. Pohlmeyer-Esch, N. Mehdi, D. Clarke & S. Radhofer-Welte. (1997) Evaluation of chronic oral toxicity and carcinogenic potential of lornoxicam in rats. Food and Chemical Toxicology 35:9, pages 909-922.
Crossref
Crossref
David M. Stresser & David Kupfer. (1997)
Catalytic Characteristics of CYP3A4: Requirement for a Phenolic Function in
ortho
Hydroxylation of Estradiol and Mono-
O
-demethylated Methoxychlor
. Biochemistry 36:8, pages 2203-2210.
Crossref
Crossref
Andrew S Wilson, Dominic P Williams, Carl D. Davis, Malcolm D Tingle & B.Kevin Park. (1997) Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 373:2, pages 257-264.
Crossref
Crossref
Bang Qian Xu, Tor A. Aasmundstad, Asbjørg S. Christophersen, Jørg Mørland & Anders Bjørneboe. (1997) Evidence for CYP2D1-mediated primary and secondary O-dealkylation of ethylmorphine and codeine in rat liver microsomes. Biochemical Pharmacology 53:4, pages 603-609.
Crossref
Crossref
A. David Rodrigues & Shekman L. Wong. 1997.
65
101
.
D.B. Campbell. 1997. Proceedings XIVth International Symposium on Medicinal Chemistry. Proceedings XIVth International Symposium on Medicinal Chemistry
45
60
.
PW van Vliet & J. de Jongh. (2016) Biokinetics and biokinetic models in risk assessment. Human & Experimental Toxicology 15:10, pages 799-809.
Crossref
Crossref
Nuzhat Zaman, Yun K Tam, Lawrence D Jewell & Ronald T Coutts. (1996) Effects of Light-Exposed Parenteral Nutrition on Hepatic Function and Lidocaine Metabolism: A Study Using Isolated Rat Liver Perfusion. Pediatric Research 40:2, pages 280-287.
Crossref
Crossref
Jurgen Schmider, David J. Greenblatt, Lisa L. von Moltke & Richard I. Shader. (1996) Relationship of In Vitro Data on Drug Metabolism to In Vivo Pharmacokinetics and Drug Interactions. Journal of Clinical Psychopharmacology 16:4, pages 267-272.
Crossref
Crossref
Malle Jurima-romet, Frank S. Abbott, Wei Tang, Hide S. Huang & larry W. Whitehouse. (1996) Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. Toxicology 112:1, pages 69-85.
Crossref
Crossref
Peter H. Roos & Axel Mahnke. (1996) Metabolite complex formation of orphenadrine with cytochrome P450. Biochemical Pharmacology 52:1, pages 73-84.
Crossref
Crossref
G. Gordon Gibson & Paul SkettG. Gordon Gibson & Paul Skett. 1994. Introduction to Drug Metabolism. Introduction to Drug Metabolism
133
156
.
S.A. Wood, A.H. Parton, R.J. Simmonds & D. Stevenson. (1996) Stereoselective metabolism of two keto-pyrrol analogues of 8-hydroxy-2-dipropyl-aminotetralin by freshly isolated rat hepatocytes. Chirality 8:3, pages 264-270.
Crossref
Crossref
Paul M. O'Neill, Malcolm D. Tingle, Roziahanim Mahmud, Richard C. Storr, Stephen A. Ward & B. Kevin Park. (1995) The effect of fluorine substitution on the haemotoxicity of Primaquine. Bioorganic & Medicinal Chemistry Letters 5:20, pages 2309-2314.
Crossref
Crossref
Collen M. Masimirembwa & Julia A. Hasler. (1994) Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochemical Pharmacology 48:9, pages 1779-1783.
Crossref
Crossref
Grace L. Earl-Salotti & Scott L. Charland. (2016) Review: The Effect of Parenteral Nutrition on Hepatic Cytochrome P-450. Journal of Parenteral and Enteral Nutrition 18:5, pages 458-465.
Crossref
Crossref
Gabrielle M. Hawksworth. (2016) Advantages and Disadvantages of Using Human Cells for Pharmacological and Toxicological Studies. Human & Experimental Toxicology 13:8, pages 568-573.
Crossref
Crossref
Menicagli Silvia, Longo Vincenzo, Mazzaccaro Arturo & Gervasi Pier Giovanni. (1994) Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liver. Biochemical Pharmacology 48:4, pages 717-726.
Crossref
Crossref
H.M. Barham, M.S. Lennard & G.T. Tucker. (1994) An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: Relevance to its use as a model of the CYP2d6 poor metaboliser phenotype. Biochemical Pharmacology 47:8, pages 1295-1307.
Crossref
Crossref
Adalbert Gerard Rauws & Kees Groen. (2016) Future Perspectives on Toxicokinetics: A Regulator's View. Drug Information Journal 28:1, pages 295-300.
Crossref
Crossref
O. Pelkonen & D. D. Breimer. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs
289
332
.
C. Charuel. 1994. Use of Mechanistic Information in Risk Assessment. Use of Mechanistic Information in Risk Assessment
242
249
.
Susan J. Sulakhe‐Hemmings & Hongmei Xing. (2004) Characterization of γ‐glutamyltranspeptidase in the liver of the frog: 1. Comparison to the rat liver enzyme. Cell Biochemistry and Function 12:1, pages 11-19.
Crossref
Crossref
Haiyung Cheng & William J. Jusko. (2006) Pharmacokinetics of reversible metabolic systems. Biopharmaceutics & Drug Disposition 14:9, pages 721-766.
Crossref
Crossref
Gerben A.E. van't Klooster, Bas J. Blaauboer, Jan Noordhoek & Adelbert S.J.P.A.M. van Miert. (1993) Cytochrome P450 induction and metabolism of alkoxyresorufins, ethylmorphine and testosterone in cultured hepatocytes from goats, sheep and cattle. Biochemical Pharmacology 46:10, pages 1781-1790.
Crossref
Crossref
Jeroen T.M. Buters, Claus D. Schiller & Ruby C. Chou. (1993) A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Biochemical Pharmacology 46:9, pages 1577-1584.
Crossref
Crossref
S. Ward & D.J. Back. (1993) Metabolism of gestodene in human liver cytosol and microsomes in vitro. The Journal of Steroid Biochemistry and Molecular Biology 46:2, pages 235-243.
Crossref
Crossref
S.M. Abel, D.J. Back, J.L. Maggs & B.K. Park. (1993) Cortisol metabolism in vitro—II. Species difference. The Journal of Steroid Biochemistry and Molecular Biology 45:5, pages 445-453.
Crossref
Crossref
D. A. Smith. (1993) Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment. European Journal of Drug Metabolism and Pharmacokinetics 18:1, pages 31-39.
Crossref
Crossref
Lisa L. Von Moltke, Melanie Manis, Jerold S. Harmatz, Roger Poorman & David J. Greenblatt. (2006)
Inhibition of acetaminophen and lorazepam glucuronidation
in vitro
by probenecid
. Biopharmaceutics & Drug Disposition 14:2, pages 119-130.
Crossref
Crossref
I.R. WEBBBR & D.J. BACK. (1993) Effect of etretinate on cyclosporin metabolism in vitro. British Journal of Dermatology 128:1, pages 42-44.
Crossref
Crossref
Jean-Marc Trivier, Christian Libersa, Claire Belloc & Michel Lhermitte. (1993) Amiodarone N-deethylation in human liver microsomes : Involvement of cytochrome P450 3A enzymes (first report). Life Sciences 52:10, pages PL91-PL96.
Crossref
Crossref
Gerben A.E. Van't Klooster, G.J.M.Jean Horbach, Masahiro Natsuhori, Bas J. Blaauboer, Jan Noordhoek & Adelbert S.J.P.A.M. Van Miert. (1993) Hepatic cytochrome P450 induction in goats. Biochemical Pharmacology 45:1, pages 113-122.
Crossref
Crossref
Charles F. Neville, Ninomiya Shin-Ichi, Shimada Noriaki, Kamataki Tetsuya, Imaoka Susumu & Funae Yoshihiko. (1993) Characterization of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochemical Pharmacology 45:1, pages 59-65.
Crossref
Crossref
Munir Pirmohamed, Neil R. Kitteringham, Alasdair M. Breckenridge & B.Kevin Park. (1992) The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochemical Pharmacology 44:12, pages 2307-2314.
Crossref
Crossref
Dennis A. Smith & Barry C. Jones. (1992) Speculations on the Substrate Structure-Activity Relationship (SSAR) of cytochrome P450 enzymes. Biochemical Pharmacology 44:11, pages 2089-2098.
Crossref
Crossref
M. Varga. (1992) Understanding the role of oxyradicals in general and in toxic hepatic damage can help safer drug design. Medical Hypotheses 39:2, pages 133-136.
Crossref
Crossref
Gerben A.E. van 't Klooster, Felice M.A. Woutersen-van Nijnanten, Herman J. Kolker, Jan Noordhoek & Adelbert S.J.P.A.M. van Miert. (1992) Improved high-performance liquid chromatographic method for the determination of ethylmorphine and its metabolites in microsomal incubations and cell culture media. Journal of Chromatography B: Biomedical Sciences and Applications 579:1, pages 158-164.
Crossref
Crossref